Early Follicular Supplementation of Ganirelix in IVF 2004

• Status: Completed
• Trial end date: 2007-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

Our goal was to investigate whether early follicular supplementation of the GnRH antagonist to the flexible GnRH antagonist protocol, has a potential to improve IVF-ET clinical results

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Baruch Padeh Medical Center, Poriya
• Collaborator: Organon
• Treatments: Ganirelix

Criteria

Inclusion Criteria:

• infertility

• IVF candidate

• failure of previous IVF attempt

Exclusion Criteria:

• low ovarian reserve

• untreated distortion of uterine cavity

• medical contraindication for IVF treatment